Advertisement
Original research article| Volume 91, ISSUE 1, P80-84, January 2015

Performance of a checklist to exclude pregnancy at the time of contraceptive initiation among women with a negative urine pregnancy test

  • Jaspur Min
    Affiliations
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
    Search for articles by this author
  • Christina Buckel
    Affiliations
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
    Search for articles by this author
  • Gina M. Secura
    Affiliations
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
    Search for articles by this author
  • Jeffrey F. Peipert
    Affiliations
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
    Search for articles by this author
  • Tessa Madden
    Correspondence
    Corresponding author. Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, 4533 Clayton Avenue, Campus Box 8219, St. Louis, MO 63110, USA. Tel.: +1 314 747 6495; fax: +1 314 747 4019.
    Affiliations
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA
    Search for articles by this author

      Abstract

      Objective

      Our objective was to measure the sensitivity and specificity of a six-item “pregnancy checklist” at excluding early- or luteal-phase pregnancy among women with a negative urine pregnancy test who were initiating contraception.

      Study design

      This was a secondary analysis of the Contraceptive CHOICE Project, a prospective cohort study of 9256 women in the St. Louis region. Women who had a negative urine pregnancy test on the day of enrollment were included in this analysis. Women with a positive urine pregnancy test or without urine pregnancy testing were excluded. We identified all luteal-phase pregnancies that occurred among women with a negative urine pregnancy test. We calculated the sensitivity, specificity, positive predictive value and negative predictive value (NPV) and likelihood ratios of the pregnancy checklist for excluding luteal-phase pregnancies.

      Results

      There were 6929 women included in this analysis; 69% of these women met at least one checklist criterion to exclude pregnancy (“negative screen”). There were 36 luteal-phase pregnancies (0.5%) subsequently diagnosed among women with a negative urine pregnancy test. The sensitivity and specificity of the checklist were 77.7% and 69.1%, respectively. The NPV of the checklist was 99.8% and the positive predictive value was 1.3%.

      Conclusion

      Among women with a negative urine pregnancy test, the pregnancy checklist can be used to safely exclude more than 99% of early pregnancies at the time of contraceptive initiation.

      Implications

      In patients with a negative urine pregnancy test, a pregnancy checklist using six criteria based on patient history has high NPV in excluding early pregnancy. This checklist can be used to facilitate same-day initiation of contraceptive methods, including long-acting reversible contraception. Although the checklist had a high false positive rate, initiation of contraception should not be delayed in women with a “positive screen.” Rather women who desire an intrauterine device or implant can be “bridged” with a shorter-acting method until pregnancy can be excluded.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Winner B.
        • Peipert J.F.
        • Zhao Q.
        • Buckel C.
        • Madden T.
        • Allsworth J.E.
        • et al.
        Effectiveness of long-acting reversible contraception.
        N Engl J Med. 2012; 366: 1998-2007
        • Trussell J.
        Contraceptive failure in the United States.
        Contraception. 2011; 83: 397-404
        • Brahmi D.
        • Steenland M.W.
        • Renner R.M.
        • Gaffield M.E.
        • Curtis K.M.
        Pregnancy outcomes with an IUD in situ: a systematic review.
        Contraception. 2012; 85: 131-139
        • Bergin A.
        • Tristan S.
        • Terplan M.
        • Gilliam M.L.
        • Whitaker A.K.
        A missed opportunity for care: two-visit IUD insertion protocols inhibit placement.
        Contraception. 2012; 86: 694-697
        • Cervinski M.A.
        • Gronowski A.M.
        Reproductive-endocrine point-of-care testing: current status and limitations.
        Clin Chem Lab Med. 2010; 48: 935-942
        • Stanback J.
        • Qureshi Z.
        • Sekadde-Kigondu C.
        • Gonzalez B.
        • Nutley T.
        Checklist for ruling out pregnancy among family-planning clients in primary care.
        Lancet. 1999; 354: 566
        • Tepper N.K.
        • Marchbanks P.A.
        • Curtis K.M.
        Use of a checklist to rule out pregnancy: a systematic review.
        Contraception. 2013; 87: 661-665
        • Stanback J.
        • Nakintu N.
        • Qureshi Z.
        • Nasution M.
        Does assessment of signs and symptoms add to the predictive value of an algorithm to rule out pregnancy?.
        J Fam Plann Reprod Health Care. 2006; 32: 27-29
        • Stanback J.
        • Nanda K.
        • Ramirez Y.
        • Rountree W.
        • Cameron S.B.
        Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua.
        Rev Panam Salud Publica. 2008; 23: 116-118
        • Torpey K.
        • Mwenda L.
        • Kabaso M.
        • Malebe T.
        • Makelele P.
        • Mwema F.
        • et al.
        Excluding pregnancy among women initiating antiretroviral therapy: efficacy of a family planning job aid.
        BMC Public Health. 2010; 10: 249
        • Stanback J.
        • Diabate F.
        • Dieng T.
        • de Morales T.D.
        • Cummings S.
        • Traore M.
        Ruling out pregnancy among family planning clients: the impact of a checklist in three countries.
        Stud Fam Plann. 2005; 36: 311-315
        • Division of Reproductive Health, Centers for Disease Control and Prevention
        U.S. Selected Practice Recommendations for Contraceptive Use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use.
        in: 2nd ed. MMWR Recomm Rep. 62. 2013: 1-60
        • Secura G.M.
        • Allsworth J.E.
        • Madden T.
        • Mullersman J.L.
        • Peipert J.F.
        The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.
        Am J Obstet Gynecol. 2010; 203: 115.e1-115.e7
        • Westhoff C.
        • Kerns J.
        • Morroni C.
        • Cushman L.F.
        • Tiezzi L.
        • Murphy P.A.
        Quick start: novel oral contraceptive initiation method.
        Contraception. 2002; 66: 141-145
        • Sneed R.
        • Westhoff C.
        • Morroni C.
        • Tiezzi L.
        A prospective study of immediate initiation of depo medroxyprogesterone acetate contraceptive injection.
        Contraception. 2005; 71: 99-103
        • Schafer J.E.
        • Osborne L.M.
        • Davis A.R.
        • Westhoff C.
        Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive.
        Contraception. 2006; 73: 488-492
        • Nelson A.L.
        • Katz T.
        Initiation and continuation rates seen in 2-year experience with same day injections of DMPA.
        Contraception. 2007; 75: 84-87